Advertisement for a medicinal product - Defumoxan 1.5 mg tablets
advertisement
| Naam | Defumoxan |
|---|---|
| Versie | 1.0.0 |
| Update | 27 nov. 2023 |
| Grootte | 36 MB |
| Categorie | Gezondheid en fitness |
| Installaties | 5K+ |
| Ontwikkelaar | Aflofarm Czech Republic s.r.o. |
| Android OS | Android 4.4+ |
| Google Play ID | com.aflofarm.defumoxan |
Defumoxan · Schermafbeeldingen
Defumoxan · Beschrijving
Read the package leaflet carefully.
Defumoxan 1.5 mg tablets are an oral medicine.
Each tablet contains 1.5 mg cytisine. Indications for use: Quitting smoking and reducing the appetite for nicotine in smokers who are willing to quit smoking. The goal of treatment with Defumoxan is to permanently stop using nicotine-containing products. Contraindications: This medicinal product should not be used in patients with hypersensitivity to the active substance or to any of the excipients, with unstable angina pectoris, with clinically significant arrhythmias, after a recent heart attack or stroke, during pregnancy and during breast-feeding.
This application is published by Aflofarm Czech Republic s.r.o., which is solely responsible for its content.
The application is intended for the public in the Czech Republic.
Defumoxan 1.5 mg tablets are an oral medicine.
Each tablet contains 1.5 mg cytisine. Indications for use: Quitting smoking and reducing the appetite for nicotine in smokers who are willing to quit smoking. The goal of treatment with Defumoxan is to permanently stop using nicotine-containing products. Contraindications: This medicinal product should not be used in patients with hypersensitivity to the active substance or to any of the excipients, with unstable angina pectoris, with clinically significant arrhythmias, after a recent heart attack or stroke, during pregnancy and during breast-feeding.
This application is published by Aflofarm Czech Republic s.r.o., which is solely responsible for its content.
The application is intended for the public in the Czech Republic.
